EyePoint Pharmaceuticals(EYPT) - 2024 Q4 - Annual Results
EyePoint Pharmaceuticals(EYPT)2025-01-13 12:05UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 EyePoint Pharmaceuticals, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 000-51122 26-2774444 (State or Other Jurisdiction of Incorporation) 480 Pleasant Street Watertown, Massachusetts 02472 (Address of Principal Executive Offices) (Zip Code) (Commission ...